Swim training prevents hyperglycemia in ZDF rats: Mechanisms involved in the partial maintenance of β-cell function

American Journal of Physiology - Endocrinology and Metabolism

Volumn 294, Issue 2, 2008, Pages

  Király, Michael A ^a   Bates, Holly E ^a   Kaniuk, Natalia A ^b   Yue, Jessica T Y ^a   Brumell, John H ^a,b   Matthews, Stephen G ^a   Riddell, Michael C ^c   Vranic, Mladen ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c YORK UNIVERSITY   (Canada)

Author keywords

cell function; cell mass; Apoptosis; C peptide; Diabetes; Exercise; Glucose transporter 2; Glycemia; Insulin; Islet morphology; Proliferation; Protein kinase B; Zucker diabetic fatty

Indexed keywords

BROXURIDINE; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN; PROTEIN KINASE B;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL SIZE; CONTROLLED STUDY; EXERCISE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; SWIMMING; ZUCKER DIABETIC FATTY RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; C-PEPTIDE; CELL COUNT; CELL PROLIFERATION; EATING; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 2; HYPERGLYCEMIA; IMAGE PROCESSING, COMPUTER-ASSISTED; IN SITU NICK-END LABELING; INSULIN; INSULIN-SECRETING CELLS; MALE; OBESITY; ONCOGENE PROTEIN V-AKT; PHYSICAL CONDITIONING, ANIMAL; POSTPRANDIAL PERIOD; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, ZUCKER; SWIMMING;

EID: 38949092116     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00476.2007     Document Type: Article

References (57)

1. Accili D. A kinase in the life of the beta cell. J Clin Invest 108: 1575-1576, 2001.
2. Bates HE, Kiraly MA, Yue JTY, Goche Montes D, Elliott ME, Riddell MC, Matthews SG, Vranic M. Recurrent intermittent restraint delays fed and fasting hyperglycemia and improves glucose return to baseline levels during glucose tolerance tests in the Zucker diabetic fatty rat-role of food intake and corticosterone. Metabolism 56: 1065-1075, 2007.
3. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 108: 1631-1638, 2001.
4. Bonner-Weir S. Regulation of pancreatic beta-cell mass in vivo. Recent Prog Horm Res 49: 91-104, 1994.
5. Briaud I, Lingohr MK, Dickson LM, Wrede CE, Rhodes CJ. Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic beta-cells. Diabetes 52: 974-983, 2003.
6. Bukau B, Weissman J, Horwich A. Molecular chaperones and protein quality control. Cell 125: 443-451, 2006.
7. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110, 2003.
8. Butler AE, Janson J, Soeller WC, Butler PC. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52: 2304-2314, 2003.
9. Chan TO, Rittenhouse SE, Tsichlis PN. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Annu Rev Biochem 68: 965-1014, 1999.
10. Christ CY, Hunt D, Hancock J, Garcia-Macedo R, Mandarino LJ, Ivy JL. Exercise training improves muscle insulin resistance but not insulin receptor signaling in obese Zucker rats. J Appl Physiol 92: 736-744, 2002.
11. Clark JB, Palmer CJ, Shaw WN. The diabetic Zucker fatty rat. Proc Soc Exp Biol Med 173: 68-75, 1983.
12. Coskun O, Ocakci A, Bayraktaroglu T, Kanter M. Exercise training prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Tohoku J Exp Med 203: 145-154, 2004.
13. Davalli AM, Ricordi C, Socci C, Braghi S, Bertuzzi F, Fattor B, Di C, V, Pontiroli AE, Pozza G. Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. J Clin Endocrinol Metab 72: 202-208, 1991.
14. Defronzo RA. Insulin secretion, insulin resistance, obesity. Int J Obes 6, Suppl 1: 73-82, 1982.
15. Defronzo RA, Hendler R, Simonson D. Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes 31: 795-801, 1982.
16. Dela F, von Linstow ME, Mikines KJ, Galbo H. Physical training may enhance beta-cell function in type 2 diabetes. Am J Physiol Endocrinol Metab 287: E1024-E1031, 2004.
17. de Lemos ET, Reis F, Baptista S, Pinto R, Sepodes B, Vala H, Rocha-Pereira P, Silva AS, Teixeira F. Exercise training is associated with improved levels of C-reactive protein and adiponectin in ZDF (type 2) diabetic rats. Med Sci Monit 13: BR168-BR174, 2007.
18. Dickson LM, Rhodes CJ. Pancreatic beta-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt? Am J Physiol Endocrinol Metab 287: E192-E198, 2004.
19. Eizirik DL, Korbutt GS, Hellerstrom C. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J Clin Invest 90: 1263-1268, 1992.
20. Finegood DT, McArthur MD, Kojwang D, Thomas MJ, Topp BG, Leonard T, Buckingham RE. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 50: 1021-1029, 2001.
21. Fujimuro M, Yokosawa H. Production of antipolyubiquitin monoclonal antibodies and their use for characterization and isolation of polyubiquitinated proteins. Methods Enzymol 399: 75-86, 2005.
22. Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, Scherer P, Rossetti L, Barzilai N. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 51: 2951-2958, 2002.
23. Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks JR, McNeish JD, Coleman KG. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 112: 197-208, 2003.
24. Harmon JS, Gleason CE, Tanaka Y, Poitout V, Robertson RP. Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats. Diabetes 50: 2481-2486, 2001.
25. Hayek A, Woodside W. Correlation between morphology and function in isolated islets of the Zucker rat. Diabetes 28: 565-569, 1979.
26. Hevener AL, Reichart D, Olefsky J. Exercise and thiazolidinedione therapy normalize insulin action in the obese Zucker fatty rat. Diabetes 49: 2154-2159, 2000.
27. Jetton TL, Lausier J, Larock K, Trotman WE, Larmie B, Habibovic A, Peshavaria M, Leahy JL. Mechanisms of compensatory beta-cell growth in insulin-resistant rats: roles of Akt kinase. Diabetes 54: 2294-2304, 2005.
28. Johnson JH, Ogawa A, Chen L, Orci L, Newgard CB, Alam T, Unger RH. Underexpression of beta cell high Km glucose transporters in non-insulin-dependent diabetes. Science 250: 546-549, 1990.
29. Kahn SE. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus. Am J Med 108, Suppl 6a: 2S-8S, 2000.
30. Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, Hori M. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48: 2398-2406, 1999.
31. Kaniuk NA, Kiraly M, Bates H, Vranic M, Volchuk A, Brumell JH. Ubiquitinated-protein aggregates form in pancreatic beta-cells during diabetes-induced oxidative stress and are regulated by autophagy. Diabetes 56: 930-939, 2007.
32. Khan A, Narangoda S, Ahren B, Holm C, Sundler F, Efendic S. Long-term leptin treatment of ob/ob mice improves glucose-induced insulin secretion. Int J Obes Relat Metab Disord 25: 816-821, 2001.
33. Kibenge MT, Chan CB. The effects of high-fat diet on exercise-induced changes in metabolic parameters in Zucker fa/fa rats. Metabolism 51: 708-715, 2002.
34. Kiraly MA, Bates HE, Yue JT, Goche-Montes D, Fediuc S, Park E, Matthews SG, Vranic M, Riddell MC. Attenuation of type 2 diabetes mellitus in the male Zucker diabetic fatty rat: the effects of stress and non-volitional exercise. Metabolism 56: 732-744, 2007.
35. Kloppel G, Clemens A. Insulin-Dependent Diabetes Mellitus: Islet Changes in Relation to Etiology and Pathogenesis. Endocr Pathol 8: 273-282, 1997.
36. Lambillotte C, Gilon P, Henquin JC. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest 99: 414-423, 1997.
37. Lamontagne J, Masiello P, Marcil M, Delghingaro-Augusto V, Burelle Y, Prentki M, Nolan CJ. Circulating lipids are lowered but pancreatic islet lipid metabolism and insulin secretion are unaltered in exercisetrained female rats. Appl Physiol Nutr Metab 32: 241-248, 2007.
38. Lazar MA. How obesity causes diabetes: not a tall tale. Science 307: 373-375, 2005.
39. Lingohr MK, Buettner R, Rhodes CJ. Pancreatic beta-cell growth and survival-a role in obesity-linked type 2 diabetes? Trends Mol Med 8: 375-384, 2002.
40. Nyblom HK, Nord LI, Andersson R, Kenne L, Bergsten P. Glucose-induced de novo synthesis of fatty acyls causes proportional increases in INS-1E cellular lipids. NMR Biomed 2007 Aug 9 [Epub ahead of print].
41. Ohneda M, Inman LR, Unger RH. Caloric restriction in obese prediabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence. Diabetologia 38: 173-179, 1995.
42. Pick A, Clark J, Kubstrup C, Levisetti M, Pugh W, Bonner-Weir S, Polonsky KS. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes 47: 358-364, 1998.
43. Pold R, Jensen LS, Jessen N, Buhl ES, Schmitz O, Flyvbjerg A, Fujii N, Goodyear LJ, Gotfredsen CF, Brand CL, Lund S. Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 54: 928-934, 2005.
44. Rhodes CJ, White MF. Molecular insights into insulin action and secretion. Eur J Clin Invest 32, Suppl 3: 3-13, 2002.
45. Robertson RP, Harmon J, Tran PO, Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53, Suppl 1: S119-S124, 2004.
46. Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S. Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138: 1736-1741, 1997.
47. Shima K, Zhu M, Noma Y, Mizuno A, Murakami T, Sano T, Kuwajima M. Exercise training in Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus: effects on the B-cell mass, insulin content and fibrosis in the pancreas. Diabetes Res Clin Pract 35: 11-19, 1997.
48. Srinivasan S, Bernal-Mizrachi E, Ohsugi M, Permutt MA. Glucose promotes pancreatic islet beta-cell survival through a PI 3-kinase/Akt-signaling pathway. Am J Physiol Endocrinol Metab 283: E784-E793, 2002.
49. Szeto J, Kaniuk NA, Canadien V, Nisman R, Mizushima N, Yoshimori T, Bazett-Jones DP, Brumell JH. ALIS are stress-induced protein storage compartments for substrates of the proteasome and autophagy. Autophagy 2: 189-199, 2006.
50. Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA 96: 10857-10862, 1999.
51. Thorens B, Sarkar HK, Kaback HR, Lodish HF. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells. Cell 55: 281-290, 1988.
52. Tokuyama Y, Sturis J, DePaoli AM, Takeda J, Stoffel M, Tang J, Sun X, Polonsky KS, Bell GI. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44: 1447-1457, 1995.
53. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, Birnbaum MJ. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med 7: 1133-1137, 2001.
54. Wang MY, Shimabukuro M, Lee Y, Trinh KY, Chen JL, Newgard CB, Unger RH. Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function. Diabetes 48: 1020-1025, 1999.
55. Wang Q, Li L, Xu E, Wong V, Rhodes C, Brubaker PL. Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells. Diabetologia 47: 478-487, 2004.
56. Westermark P, Wilander E. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 15: 417-421, 1978.
57. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391: 900-904, 1998.